Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PIK3R2 Antikörper (AA 1-60)

Der Kaninchen Polyklonal anti-PIK3R2 Antikörper wird verwendet zum Nachweis von PIK3R2 in Proben von Human, Ratte und Maus. Er wurde validiert für WB, ELISA, IHC und IF.
Produktnummer ABIN7230630
546,69 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 10 bis 14 Werktagen

Kurzübersicht für PIK3R2 Antikörper (AA 1-60) (ABIN7230630)

Target

Alle PIK3R2 (PI3K p85b) Antikörper anzeigen
PIK3R2 (PI3K p85b) (Phosphoinositide 3 Kinase, p85 beta (PI3K p85b))

Reaktivität

  • 133
  • 70
  • 32
  • 18
  • 14
  • 4
  • 1
  • 1
  • 1
  • 1
Human, Ratte, Maus

Wirt

  • 122
  • 11
Kaninchen

Klonalität

  • 100
  • 33
Polyklonal

Konjugat

  • 61
  • 9
  • 8
  • 7
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Dieser PIK3R2 Antikörper ist unkonjugiert

Applikation

  • 105
  • 47
  • 47
  • 19
  • 17
  • 13
  • 13
  • 13
  • 12
  • 12
  • 6
  • 3
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
  • Bindungsspezifität

    • 15
    • 9
    • 8
    • 8
    • 8
    • 6
    • 5
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-60

    Verwendungszweck

    Rabbit Anti-PI 3-Kinase p85β Polyclonal Antibody

    Spezifität

    The antibody detects endogenous levels of PI 3-Kinase p85β

    Aufreinigung

    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

    Immunogen

    Synthesized peptide derived from part region of human PI 3-Kinase p85beta protein at AA range: 1-60

    Isotyp

    IgG
  • Applikationshinweise

    Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,IHC 1:50-200,ELISA 1:10000-20000,IF 1:50-200

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 mg/mL

    Buffer

    Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

    Haltbarkeit

    12 months
  • Target

    PIK3R2 (PI3K p85b) (Phosphoinositide 3 Kinase, p85 beta (PI3K p85b))

    Andere Bezeichnung

    PI 3-Kinase p85beta

    Hintergrund

    Phosphatidylinositol 3-kinase regulatory subunit beta, PI3-kinase regulatory subunit beta, PI3K regulatory subunit beta, PtdIns-3-kinase regulatory subunit beta, Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta, PI3-kinase subunit p85-beta, PtdIns-3-kinase regulatory subunit p85-betaPhosphatidylinositol 3-kinase (PI3K) is a lipid kinase that phosphorylates phosphatidylinositol and similar compounds, creating second messengers important in growth signaling pathways. PI3K functions as a heterodimer of a regulatory and a catalytic subunit. The protein encoded by PIK3R2 is a regulatory component of PI3K. Two transcript variants, one protein coding and the other non-protein coding, have been found for PIK3R2. PIK3R2 (Phosphoinositide-3-Kinase Regulatory Subunit 2) is a Protein Coding gene. Diseases associated with PIK3R2 include Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome 1 and Mpph Syndrome. Among its related pathways are 4-1BB Pathway and Common Cytokine Receptor Gamma-Chain Family Signaling Pathways.

    Gen-ID

    5296

    UniProt

    O00459

    Pathways

    VEGF Signaling, BCR Signaling
Sie sind hier:
Chat with us!